Lifeline Biotechnologies Market Cap

Lifeline Biotechnologies has a market cap or net worth of $2.61 million as of March 6, 2026. Its market cap has decreased by -60.00% in one year.

Market Cap

2.61M

Enterprise Value

n/a

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since December 31, 2003, Lifeline Biotechnologies's market cap has decreased from 18.97M to 2.61M, a decrease of -86.25%. That is a compound annual growth rate of -8.55%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	2.61M	-14.29%
Dec 31, 2025	3.04M	600.00%
Dec 31, 2024	434.89K	-35.07%
Dec 28, 2023	669.78K	-33.33%
Dec 30, 2022	1.00M	50.00%
Dec 31, 2021	669.78K	-60.00%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AI Maverick Intel	2.70M
Fuse Medical	2.82M
Vycor Medical	3.27M
CYduct Diagnostics	3.90M
Escalon Medical	1.71M
STRATA Skin Sciences	1.53M
Co-Diagnostics	5.26M
Nu-Med Plus	1.28M

Market Cap Rankings